Search

Your search keyword '"Lacasce, A. S."' showing total 730 results

Search Constraints

Start Over You searched for: Author "Lacasce, A. S." Remove constraint Author: "Lacasce, A. S."
730 results on '"Lacasce, A. S."'

Search Results

1. Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease

4. A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma

5. Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States

8. Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

10. A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia

12. Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation

13. A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma

17. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

18. Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.

20. Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study

22. Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma

23. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

24. PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

28. Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial

29. PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

30. Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015.

33. Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP

34. Non-Hodgkin's lymphomas, version 4.2014.

37. Positron emission tomography–computed tomography predictors of progression after DA-R-EPOCH for PMBCL

38. Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation

40. Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma

42. NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023

43. A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma

44. Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1

46. Atorvastatin for Anthracycline-Associated Cardiac Dysfunction

Catalog

Books, media, physical & digital resources